Michelle Lee, IPO 2016 US patent owners list, Sanofi, Amgen, Puma, Forever 21, TC Heartland and 101 rulings, Apple, WARF – the week in IP

June 08 2017

Speculation about why Michelle Lee resigned as USPTO director, the IPO releasing its list of the top 300 organisations granted US patents, Federal Circuit arguments in Amgen and Sanofi’s dispute over cholesterol drug patents, a setback for Puma in its lawsuit against Forever 21, how TC Heartland will affect Section 101 rulings, and an affirmation of a $234m verdict against Apple were in the recent intellectual property news

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login

Topics

more from across site and SHARED ros bottom lb

More from across our site

Patents

Richard-de-Bodo_Bio-Pic-500x (2) (1).png

Post ‘big law’ stage: why Barton’s latest partner is keen to offer ‘something better’

Richard de Bodo, who had a lengthy career at international firms, shares how he will address client needs and praises the unique offerings of smaller firms

Sanjana Mishra, May 15 2026

Patents

This week on MIP: UK TM licensing ruling reversed | Dua Lipa sues Samsung

An Australian top court decision clarifying honest concurrent use and wins by publishers against AI platforms were also among the top talking points

May 15 2026

Patents

Blick auf die Business Bay in Dubai mit den modernen Wolkenkratzern bei Sonnenaufgang

Weekly take: Why AIPPI and INTA’s Dubai problem can’t be easily fixed

AIPPI has pulled the plug on its planned 2027 World Congress, and INTA has delayed hosting a meeting there, but the concerns won’t abate

Max Walters, May 14 2026

Trademarks

King & Spalding scores largest ever Lanham Act award

Despite being outspent by a wealthy opponent, a trial attorney at King & Spalding says ‘relentless pursuit of the truth’ helped his team secure a $420m damages award for mobile gaming client

Sanjana Mishra, May 14 2026

Patents

BMS and Hengrui Pharma sign $15.2bn deal as patent cliff nears

190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo

Sukanya Sarkar, May 13 2026

Patents

close-up-of-nokia-headquarters-in-espoo-finland_0 (1).jpg

Pro-arbitration turn? Appeals court stays FRAND case against Nokia

Nokia, represented by a team from Bird & Bird, adjudged to have made fair offer to Asus and Acer in UK SEP dispute

Max Walters, May 13 2026

Trademarks

Abion’s UK founders depart in quick succession

Azhar Sadique and Kane Ridley, who founded the London office in 2023, are now both working in legal tech and AI-related roles, while another UK-based lawyer has also left

May 13 2026

Trademarks

Magnifying glass emphasizing one glowing figure among group symbolizing focused hiring

Familiar faces: Hoyng expands with double August Debouzy hire

Partner Pierre Pérot rejoins the firm he left in 2022 alongside another returning lawyer, associate Camille Abba

May 11 2026

Trademarks

Court of Appeal overturns unjustified threats injunction in vape TM dispute

Vaping dispute, in which Stobbs and Brandsmiths are the representatives, tested how the UK's Human Rights Act can apply to injunctions restraining unjustified threats

May 08 2026

Patents

ALMERIA, SPAIN - 02 APRIL 2023 A bronze statue of John Lennon sitting and playing the guitar in the Plaza de las Flores in Almeria, Spain

This week on MIP: Samsung to pay ZTE $392m | Lennon v Lemon TM dispute

An AI platform being sold for £40m, and lateral hires involving law firms Womble Bond Dickinson and Cadwell Thomas were among the top talking points

May 08 2026